In a COPD patient, when is home oxygen therapy indicated and how should it be prescribed (target saturation, flow rate, daily duration, and portable oxygen use)?

Home Oxygen Therapy in COPD: Indications and Prescription

Long-term oxygen therapy (LTOT) should be prescribed for stable COPD patients with severe chronic resting hypoxemia (PaO₂ ≤7.3 kPa or 55 mmHg) for a minimum of 15 hours per day, titrated to achieve SpO₂ >90% and PaO₂ ≥8 kPa (60 mmHg), using oxygen concentrators at flow rates starting at 1 L/min and increasing in 1 L/min increments. 1

Indications for Long-Term Oxygen Therapy

LTOT is indicated in the following scenarios:

• Severe chronic resting hypoxemia: PaO₂ ≤7.3 kPa (55 mmHg) on two arterial blood gas measurements taken at least 3 weeks apart during clinical stability 1, 2
• Moderate hypoxemia with complications: PaO₂ ≤8.0 kPa (60 mmHg) in the presence of peripheral edema, polycythemia (hematocrit ≥55%), or pulmonary hypertension on ECG or echocardiography 1

Critical Assessment Requirements

• Patients must be clinically stable for at least 8 weeks following their last exacerbation before formal LTOT assessment 1
• Two separate ABG measurements at least 3 weeks apart are required to confirm eligibility 1
• Initial referral should occur when resting SpO₂ is ≤92% on room air 1
• For patients with peripheral edema, polycythemia, or pulmonary hypertension, consider referral at SpO₂ ≤94% to identify those with PaO₂ ≤8 kPa 1

Prescription Parameters

Target Saturation

• Primary target: SpO₂ >90% at rest, confirmed by achieving PaO₂ ≥8 kPa (60 mmHg) on arterial blood gas 1
• During acute exacerbations: Target SpO₂ 88-92% to minimize risk of hypercapnic respiratory failure 3, 4

Flow Rate Titration

Initial titration protocol 1:

1. Start at 1 L/min
2. Increase in 1 L/min increments at 20-minute intervals
3. Continue until SpO₂ >90% is achieved
4. Perform ABG to confirm PaO₂ ≥8 kPa (60 mmHg)
5. Reassess ABG after titration to ensure no respiratory acidosis or PaCO₂ rise >1 kPa (7.5 mmHg)

Flow adjustments for specific situations 1:

• During sleep: Non-hypercapnic patients should increase flow rate by 1 L/min
• During exercise: Active outdoor patients require ambulatory oxygen assessment to determine if flow rate needs increasing
• Hypercapnic patients: Those who develop respiratory acidosis (pH <7.35) and/or PaCO₂ rise >1 kPa during assessment on two occasions should only receive oxygen in conjunction with nocturnal ventilatory support 1

Daily Duration

• Minimum requirement: 15 hours per day 1
• Optimal benefit: Up to 24 hours per day provides additional survival benefit 1, 5
• A dose-response relationship exists where greater daily usage improves survival outcomes 5

Equipment Selection

Stationary Oxygen

• Oxygen concentrators should be used for LTOT at flow rates ≤4 L/min 1
• Nasal cannulae are the first-choice delivery device 1
• Venturi masks may be preferred for patients with concerns about hypercapnic respiratory failure, high respiratory rates, or cognitive problems 1

Portable Oxygen

• Portable oxygen should be provided to patients active outdoors who meet LTOT criteria 1
• Liquid oxygen systems are recommended for mobile patients requiring >3 L/min continuous flow during exertion 2
• Oxygen-conserving devices can extend cylinder duration for patients active outside the home 1

Monitoring and Follow-Up

Initial Follow-Up

• 3-month assessment: Mandatory follow-up including blood gases and flow rate verification to ensure LTOT remains indicated and therapeutic 1
• Home visit within 4 weeks: Specialist nurse should assess compliance, smoking status, symptoms of hypercapnia, and verify oxygen saturations on oxygen 1

Ongoing Monitoring

• 6-12 month intervals: Regular follow-up visits (home-based or hospital) by specialist home oxygen assessment team 1
• Each visit should assess blood gases, flow rate adequacy, patient education needs, and potential for oxygen withdrawal 1

Critical Pitfalls to Avoid

Hypercapnic Risk Management

• Patients who develop respiratory acidosis (pH <7.35) and/or PaCO₂ rise >1 kPa during assessment require further medical optimization and reassessment after 4 weeks 1
• Never abruptly discontinue oxygen if hypercapnia develops from over-oxygenation; this can cause life-threatening rebound hypoxemia 3, 4
• During acute exacerbations with SpO₂ ~85%, initiate controlled low-flow oxygen using a 24% Venturi mask at 2-3 L/min targeting SpO₂ 88-92%, and obtain ABG within 1 hour 4

Contraindications and Special Considerations

• Active smoking: LTOT provides more limited clinical benefit in patients who continue to smoke, though this should be discussed rather than being an absolute contraindication 1
• Nocturnal oxygen alone: NOT recommended for COPD patients with nocturnal hypoxemia who fail to meet LTOT criteria 1
• Short burst oxygen therapy (SBOT): Should NOT be ordered for use before or after exercise in hypoxemic or normoxic COPD patients 1
• Palliative oxygen: Should NOT be prescribed for patients with SpO₂ ≥92% experiencing breathlessness; opiates and fan therapy should be assessed first 1

Patient Education Requirements

• Formal education by specialist home oxygen assessment team is mandatory to ensure compliance 1
• Written and verbal safety information regarding smoking cessation and fire hazards (naked flames, pilot lights, cookers, gas fires, candles) must be provided 1
• Patients discharged from hospital on oxygen must be counseled that oxygen may be removed if reassessment shows clinical improvement 1

Ambulatory Oxygen Considerations

• Ambulatory oxygen assessment is required for LTOT patients who are active outdoors to determine appropriate exercise flow rates 1
• Ambulatory and nocturnal oximetry may be performed to allow more accurate flow rate prescriptions for exercise and sleep 1
• For patients unable to safely manipulate flow rates due to cognitive, visual, or coordination impairments, maintain a single fixed flow rate 1